Clinical safety and efficacy of the first-in-class Rho kinase inhibitor for lowering IOP: netarsudil and the fixed-dose combination of netarsudil and latanoprost “Uveoscleral outflow” has been added to your cart. View cart €15.00 Clinical safety and efficacy of the first-in-class Rho kinase inhibitor for lowering IOP: netarsudil and the fixed-dose combination of netarsudil and latanoprost quantity Add to cart Category: Articles Tag: Volume 3 Description Description Authors: Janet B. Serle, Jake Radell Related products IOP homeostasis ? Why most people do not ever develop glaucoma €15.00 Add to cart Uveoscleral outflow €15.00 Add to cart Molecular differences in segmental regions of the trabecular meshwork €15.00 Add to cart Glaucoma and stem cells €15.00 Add to cart